
Join to view full profile
211 South 9th Street3rd FloorPhiladelphia, PA 19107
Phone+1 215-955-5161
Fax+1 215-923-6003
Dr. Summer is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Ross Summer is a pulmonologist in Philadelphia, PA, specializing in interstitial lung disease and chronic respiratory disorders. He completed his medical degree at Louisiana State University School of Medicine in New Orleans in 1996, followed by an Internal Medicine residency at Johns Hopkins University and a fellowship in Pulmonary and Critical Care Medicine at Boston University Medical Center.
Dr. Summer’s clinical expertise includes interstitial lung disease, sarcoidosis, idiopathic pulmonary fibrosis, and chronic respiratory failure. He has published extensively in peer‑reviewed journals on interstitial lung disease as well as basic science mechanisms of lung injury and repair. He has also participated in numerous clinical investigations, including NIH‑funded studies and industry‑sponsored clinical trials focused on pulmonary fibrosis and other respiratory conditions.
Education & Training
Boston University Medical CenterFellowship, Pulmonary Disease and Critical Care Medicine, 1999 - 2003
Johns Hopkins UniversityResidency, Internal Medicine, 1996 - 1999
Louisiana State University School of Medicine in New OrleansClass of 1996
Certifications & Licensure
PA State Medical License 2011 - 2026
MA State Medical License 1999 - 2014
American Board of Internal Medicine Critical Care Medicine
American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR (Complete), Allscripts, 2014-2017
- CMS Meaningful Use Stage 1 Certification Allscripts TouchWorks EHR, Allscripts, 2014-2017
- CMS Meaningful Use Stage 2 Certification Allscripts TouchWorks EHR, Allscripts, 2014-2017
Clinical Trials
- Autoantibody Reduction for Acute Exacerbations of Idiopathic Pulmonary Fibrosis Start of enrollment: 2018 Sep 04
Roles: Contact
- A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis Start of enrollment: 2023 Oct 25
- A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis Start of enrollment: 2023 Sep 14
Publications & Presentations
PubMed
- Immunosuppressive medication patterns in rheumatoid arthritis-associated interstitial lung disease by antifibrotic documentation status: A multicenter U.S. electronic ...Giorgos Loizidis, Pankhuri Malhotra, Michael Li, Ross Summer
Respiratory Medicine. 2026-09-01 - Reply to White and Kalluri: Response to high-flow oxygen therapy in ILD exacerbation: an imperfect therapy.Jesse Roman, Ross Summer, Gautam George
Annals of the American Thoracic Society. 2026-09-01 - GLP-1-based therapy and ICD-10-documented heart failure or respiratory failure events in non-diabetic adults with rheumatoid arthritis and obesity: a TriNetX federated...Giorgos Loizidis, Ross Summer
Clinical Rheumatology. 2026-07-01
Press Mentions
Can GLP-1 Agonists Provide Protective, Anti-Inflammatory Effects?March 12th, 2026
Hermansky-Pudlak Syndrome-2 Alters Mitochondrial Homeostasis in the Alveolar Epithelium of the LungFebruary 8th, 2021
Increasing Lipid Production Could Be Key to New Pulmonary Fibrosis Treatment, Study SaysMarch 12th, 2018
Grant Support
- Targeting Latexin Signaling for Endothelial Barrier Dysfunction in Inflammatory Lung InjuryTHOMAS JEFFERSON UNIVERSITY2021–2025
- Adiponectin Inhibits Activation And Injury Of Lung EndotheliumNational Heart, Lung, And Blood Institute2011
- The Identification And Study Of A Lung Mesenchymal Stem CellNational Heart, Lung, And Blood Institute2007–2010
- The Identification And Study- Lung Mesenchymal Stem CellNational Heart, Lung, And Blood Institute2006
Professional Memberships
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: